These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3042005)

  • 1. [Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage--results of a multi-center controlled double-blind clinical study].
    Hashi K; Takakura K; Sano K; Ohta T; Saito I; Okada K
    No To Shinkei; 1988 Apr; 40(4):373-82. PubMed ID: 3042005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.
    Muroi C; Terzic A; Fortunati M; Yonekawa Y; Keller E
    Surg Neurol; 2008 Jan; 69(1):33-9; discussion 39. PubMed ID: 18054611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of vasospasm with operative results in ruptured aneurysms].
    Nitta M; Nagai H; Hara M; Tanaka H; Shintani A; Takagi T; Hori H; Ito H; Maeda S
    No Shinkei Geka; 1982 Aug; 10(8):823-9. PubMed ID: 7133303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
    Kramer AH; Gurka MJ; Nathan B; Dumont AS; Kassell NF; Bleck TP
    Neurosurgery; 2008 Feb; 62(2):422-7; discussion 427-30. PubMed ID: 18382320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment.
    van den Bergh WM; Albrecht KW; Berkelbach van der Sprenkel JW; Rinkel GJ
    Acta Neurochir (Wien); 2003 Mar; 145(3):195-9; discussion 199. PubMed ID: 12632115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind clinical evaluation of the effect of Nizofenone (Y-9179) on delayed ischemic neurological deficits following aneurysmal rupture.
    Saito I; Asano T; Ochiai C; Takakura K; Tamura A; Sano K
    Neurol Res; 1983; 5(4):29-47. PubMed ID: 6149485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Jan; 10(1):11-7. PubMed ID: 15737948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM;
    J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naloxone on deficits after aneurysmal subarachnoid hemorrhage.
    Bell BA; Miller JD; Neto NG; O'Neill P; Laughton LM
    Neurosurgery; 1985 Apr; 16(4):498-501. PubMed ID: 3157881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study.
    Ohta T; Kikuchi H; Hashi K; Kudo Y
    J Neurosurg; 1986 Mar; 64(3):420-6. PubMed ID: 3512795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of prostacyclin in patients with ischemic stroke. A double-blind method II].
    Huczyński J; Gryglewski RJ; Kostka-Trabka E; Dembińska-Kieć A; Pykosz-Mazur E; Sotowska W; Grodzińska L; Peczak E; Bieroń K; Kedzior A
    Neurol Neurochir Pol; 1988; 22(4):299-304. PubMed ID: 3067105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multi-morbidity and pharmacotherapy in the aged. Considerations for the treatment of cerebral performance deficits].
    Platt D
    Fortschr Med; 1990 Mar; 108(9):181-3. PubMed ID: 2187783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation on glucocorticoid Administration in the Neurosurgical Patients (the second report)--Clinical study on hydrocortisone concentration in cerebrospinal fluid (author's transl)].
    Yoshimoto H; Mori S; Matsumura S; Ohta M; Oki S
    No Shinkei Geka; 1977 Aug; 5(9):941-6. PubMed ID: 917244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.